scarletred
Home
Company
Products
Scarletred
®Vision
Scarletred
®Telemedicine
Services
Applications
CAREER
News
Contact
Menu
01
Home
02
Company
03
Products
04
Services
05
Applications
06
News
07
Contact
Get in touch
Austria
SCARLETRED Holding GmbH
MQM 3.4, Maria Jacobi Gasse 1,
8th floor, 1030 Vienna, Austria
USA
SCARLETRED Inc.
1 Broadway, 14th floor,
Cambridge, MA 02142, USA
office@scarletred.com
Privacy Policy
Social
Linkedin
Linkedin
Linkedin
Twitter
Instagram
Instagram
Facebook
Facebook
info
Press
Career
FAQ
Regulatory
Imprint
Conferences
Keywords:
#
AAD 2024
#
Tissue Classifier
#
Skin Care
#
AAD 2023
#
BioJapan2022
#
JAK inhibitors
#
Safety monitoring
News
•
Sep 27, 2023
Scarletred presents study at the 32nd EADV Congress in Berlin
SCARLETRED is presenting the results of their latest publication at the 32nd EADV Congress in Berlin, Germany. The study examined the use of deep learning algorithms for erythema scoring in radiation-induced dermatitis.
News
•
Aug 21, 2023
7th Dermatology Drug Development Summit in Boston: Scarletred Joins as Lead & Hosting Partner and Expert Speaker
The 7th Dermatology Drug Development Summit in Boston, USA, for inflammatory skin diseases presents novel therapeutics for rare and common skin diseases such as Atopic Dermatitis, Hidradenitis suppurativa, and more.
News
•
Feb 27, 2023
Dermatology Drug Development Summit 2023 Hosts Scarletred as Expert Partner
Scarletred’s CEO Harald Schnidar joins the Dermatology Drug Development Summit 2023 Europe in Berlin, Germany, to speak on the topic of AI-assisted objective skin imaging and analysis.
No items found.
Paper
•
November 30, 2023
Automated Classification of Hidradenitis Suppurativa Disease Severity by Convolutional Neural Network Analyses Using Calibrated Clinical Images
Read more